Share on
HTML EMBED
Click to Copy
Marketplace Morning Report

Who are the elder scam fraudsters?

May 22, 2019

Latest Episodes

Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Tech
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report

Johnson & Johnson to pay $2.2 billion in Risperdal settlement

Nov 5, 2013
Share Now on:
HTML EMBED:
COPY

It is one of the biggest settlements of a health care fraud case ever. Johnson and Johnson has agreed to pay $2.2 billion to settle charges over how it aggressively marketed drugs in the late 90s and early 200s, including paying kickbacks to pharmacists.

The pharmaceutical giant is accused of marketing its drug Risperdal, which is approved for treating schizophrenia, as a way to treat anxiety among elderly people with dementia, even though it increased their risk of death. Doctors are allowed to prescribe drugs for unapproved or so-called “off-label” uses, but it is illegal for a company to market a drug in a way that it hasn’t been approved by federal regulators. Prosecutors say the company also promoted the drug to treat mentally ill boys — even though it could cause them to grow breasts. Johnson & Johnson is currently fighting a large number of individual lawsuits related to those accusations. 

In the settlement, Johnson & Johnson pled guilty to “introducing a misbranded drug into interstate commerce.” But in a letter to its employees, company lawyers said they strongly dispute the government’s version of events and settled just to move on and avoid lengthy legal tie ups.  

By the way, the whistleblowers whose leaks spurred this investigation stand to gain about $168 million from the government’s taking.

How We Survive
How We Survive
Climate change is here. Experts say we need to adapt. This series explores the role of technology in helping humanity weather the changes ahead.